Drug giant Pfizer halted development of its most promising experimental drug after more than 80 people died during test trials. This is a major setback for the company, Stacey Vanek-Smith reports.
The dollar was trading at a 20-month low against the euro this morning. So you'll shell out some serious dough on your next European vacation, but what else does a dropping dollar mean? Stacey Vanek-Smith reports.
The dollar's decline could push up the price of oil. Some OPEC members are calling for a cut in production because the falling dollar has amounted to a price cut for them. Stephen Beard explains.
Host Bob Moon asks Newsweek's Wall Street editor Allan Sloan how billionaire investor Kirk Kerkorian managed to walk away from $800 million worth of GM stock so gracefully — and what the move means for GM.
Seattle voters overwhelmingly passed an initiative to block future public money from being used for pro sports teams — but some are trying to work a deal for a new SuperSonics stadium anyway. Amy Radil reports.
The supermarket industry has become hotly competitive since Wal-Mart came onto the field, but Kroger has continued to post strong numbers. Diantha Parker looks at the grocery chain's winning game plan.
The U.S. is prepared to finalize a bill would allow American companies to sell civilian nuclear technology to India, but now India's wavering over some concessions in the final version. Miranda Kennedy reports.
Drive-thru customers at some Wendy's locations across the country aren't actually talking to workers inside the restaurant — and that's speeding up the line. Sheryl Rich-Kern explains.